⌘K

Login Start Free

Home/Filings/4/0001181431-14-008989

4//SEC Filing

Sagent Pharmaceuticals, Inc. 4

Accession 0001181431-14-008989

CIK 0001369786operating

View on SEC.gov Company Profile

Filed

Feb 23, 7:00 PM ET

Accepted

Feb 24, 9:43 PM ET

Size

5.8 KB

Accession

0001181431-14-008989

Insider Transaction Report

Form 4

Period: 2014-02-21

Sagent Pharmaceuticals, Inc.SGNT

VP, Sales and Marketing

Transactions

Tax Payment
Common Stock
2014-02-21$21.84/sh−388$8,474→ 25,703 total
Tax Payment
Common Stock
2014-02-22$21.75/sh−290$6,308→ 25,413 total

Documents

1 file

4
rrd403408.xmlPrimary

Issuer

Sagent Pharmaceuticals, Inc.

CIK 0001369786

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0001369786

Filing Metadata

Form type: 4
Filed: Feb 23, 7:00 PM ET
Accepted: Feb 24, 9:43 PM ET
Size: 5.8 KB

View on SEC.gov